Christophe Courdurie1, Yohann Le Govic1, Pascale Bourhy2, Dorothee Alexer1, Karine Pailla1, Rafaelle Theodose1, Raymond Cesaire3, Jacques Rosine4, Patrick Hochedez5, Claude Olive1. 1. Department of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies. 2. Department of Spirochetes Biology, Pasteur Institute, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France. 3. Department of Virology, University Hospital of Fort-de-France, Martinique, French West Indies. 4. Interregional Epidemiology Unit, French Institute for Public Health Surveillance, Fort-de-France, Martinique, French West Indies. 5. Department of Infectious Diseases, University Hospital of Fort-de-France, Martinique, French West Indies.
Abstract
BACKGROUND: Leptospirosis is a potentially life-threatening but curable zoonosis whose prognosis depends on accurate and timely diagnosis. Because of its non-specific clinical presentation, laboratory testing is essential to confirm the diagnosis. Here, we aimed to assess the performance of two enzyme-linked immunosorbent assays (ELISAs) (ELISA Serion and ELISA-Hb Pasteur) and one immunodot (GenBio) using quantitative PCR (qPCR) as gold standard, instead of the traditional microscopic agglutination test, for the diagnosis of acute leptospirosis in an endemic area. METHODOLOGY/PRINCIPAL FINDINGS: Between January 2011 and December 2012, a total of 122 patients were diagnosed with leptospirosis, as confirmed by qPCR at the University Hospital of Martinique. Among them, 103 had at least one serum sample available for analysis. Performance of each serological assay was evaluated according to days' post onset of symptoms (DPO) and local species diversity (which included L. santarosai, L. interrogans, L. kirschneri, L. borgpetersenii, L. noguchii, and L. kmetyi). Several thresholds were tested to optimize accuracy. When considering the manufacturer's threshold, the sensitivity of ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot was 75%, 67% and 64%, while specificity was 92%, 98% and 100%, respectively. Moreover, the threshold optimization allowed a significant improvement in specificity for the ELISA Serion from 92% to 99% (p<0.05). During the first 5 DPO, sensitivities were 35%, 30% and 42% for ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot, respectively. However, between 6─10 DPO, these sensitivities dramatically increased to reach 86%, 76% and 67%, respectively. Performances of the three assays were not affected by the species studied. CONCLUSIONS/SIGNIFICANCE: All these serological assays showed the potential for diagnosing leptospirosis after (but not before) 6 days' post onset of symptoms. In a high prevalence setting, where highest specificities are needed, threshold optimizing should be performed for this purpose.
BACKGROUND:Leptospirosis is a potentially life-threatening but curable zoonosis whose prognosis depends on accurate and timely diagnosis. Because of its non-specific clinical presentation, laboratory testing is essential to confirm the diagnosis. Here, we aimed to assess the performance of two enzyme-linked immunosorbent assays (ELISAs) (ELISA Serion and ELISA-Hb Pasteur) and one immunodot (GenBio) using quantitative PCR (qPCR) as gold standard, instead of the traditional microscopic agglutination test, for the diagnosis of acute leptospirosis in an endemic area. METHODOLOGY/PRINCIPAL FINDINGS: Between January 2011 and December 2012, a total of 122 patients were diagnosed with leptospirosis, as confirmed by qPCR at the University Hospital of Martinique. Among them, 103 had at least one serum sample available for analysis. Performance of each serological assay was evaluated according to days' post onset of symptoms (DPO) and local species diversity (which included L. santarosai, L. interrogans, L. kirschneri, L. borgpetersenii, L. noguchii, and L. kmetyi). Several thresholds were tested to optimize accuracy. When considering the manufacturer's threshold, the sensitivity of ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot was 75%, 67% and 64%, while specificity was 92%, 98% and 100%, respectively. Moreover, the threshold optimization allowed a significant improvement in specificity for the ELISA Serion from 92% to 99% (p<0.05). During the first 5 DPO, sensitivities were 35%, 30% and 42% for ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot, respectively. However, between 6─10 DPO, these sensitivities dramatically increased to reach 86%, 76% and 67%, respectively. Performances of the three assays were not affected by the species studied. CONCLUSIONS/SIGNIFICANCE: All these serological assays showed the potential for diagnosing leptospirosis after (but not before) 6 days' post onset of symptoms. In a high prevalence setting, where highest specificities are needed, threshold optimizing should be performed for this purpose.
Authors: Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt Journal: J Clin Epidemiol Date: 2003-11 Impact factor: 6.437
Authors: Direk Limmathurotsakul; Elizabeth L Turner; Vanaporn Wuthiekanun; Janjira Thaipadungpanit; Yupin Suputtamongkol; Wirongrong Chierakul; Lee D Smythe; Nicholas P J Day; Ben Cooper; Sharon J Peacock Journal: Clin Infect Dis Date: 2012-04-20 Impact factor: 9.079
Authors: Ampai Tanganuchitcharnchai; Lee Smythe; Michael Dohnt; Rudy Hartskeerl; Manivanh Vongsouvath; Viengmone Davong; Olay Lattana; Paul N Newton; Stuart D Blacksell Journal: Trans R Soc Trop Med Hyg Date: 2012-07-19 Impact factor: 2.184
Authors: Emi Kitashoji; Nobuo Koizumi; Talitha Lea V Lacuesta; Daisuke Usuda; Maricel R Ribo; Edith S Tria; Winston S Go; Maiko Kojiro; Christopher M Parry; Efren M Dimaano; Jose B Villarama; Makoto Ohnishi; Motoi Suzuki; Koya Ariyoshi Journal: PLoS Negl Trop Dis Date: 2015-06-25
Authors: Lisa M Esteves; Sara M Bulhões; Claudia C Branco; Teresa Carreira; Maria L Vieira; Maria Gomes-Solecki; Luisa Mota-Vieira Journal: Sci Rep Date: 2018-06-15 Impact factor: 4.379